Deucravacitinib Improves Psoriasis Symptoms and Signs Diary Domain Scores in Patients With Moderate to Severe Plaque Psoriasis: Results From the Phase 3 POETYK PSO-1 and POETYK PSO-2 Studies. J of Skin 2021, 5 (6), s38. https://doi.org/10.25251/skin.5.supp.38.